Thomas Damgaard Sandahl

  1. Journal article › Research › Peer-reviewed
  2. Published

    Single-centre experience of the macrophage activation marker soluble (s)CD163 - associations with disease activity and treatment response in patients with autoimmune hepatitis. / Grønbaek, H; Kreutzfeldt, Martin Heebøll; Kazankov, K et al.

    In: Alimentary Pharmacology and Therapeutics, Vol. 44, No. 10, 11.2016, p. 1062-1070.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  3. Published

    Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment. / Laursen, Tea Lund; Wong, Grace Lai-Hung; Kazankov, Konstantin et al.

    In: Journal of Gastroenterology and Hepatology, Vol. 3, No. 2, 2018, p. 484–491.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  4. Published

    Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation. / Rainer, F; Horvath, A; Sandahl, T D et al.

    In: Alimentary Pharmacology and Therapeutics, Vol. 47, No. 5, 03.2018, p. 657-664.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  5. Published

    Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis. / Grønbaek, H; Sandahl, T D; Mortensen, C et al.

    In: Alimentary Pharmacology and Therapeutics, Vol. 36, No. 2, 07.2012, p. 173-80.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  6. Published

    The Prevalence of Wilson’s Disease : An Update. / Sandahl, Thomas Damgaard; Laursen, Tea Lund; Munk, Ditte Emilie et al.

    In: Hepatology, Vol. 71, No. 2, 02.2020, p. 722-732.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  7. Published

    The damage-associated molecular pattern HMGB1 is elevated in human alcoholic hepatitis, but does not seem to be a primary driver of inflammation. / Laursen, Tea Lund; Støy, Sidsel; Deleuran, Bent et al.

    In: A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica, Vol. 124, No. 9, 06.2016, p. 741-7.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  8. Published

    The galactose elimination capacity test to monitor liver disease course in patients with Wilson's disease. / Munk, Ditte Emilie; Björklund, Jessica; Lund Laursen, Tea et al.

    In: Scandinavian Journal of Gastroenterology, Vol. 57, No. 5, 05.2022, p. 589-594.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  9. Published

    The lectin pathway of the complement system is downregulated in Crohn's disease patients who respond to anti-TNF-α therapy. / Sandahl, Thomas Damgaard; Kelsen, Jens; Dige, Anders et al.

    In: Journal of Crohn's & colitis, Vol. 8, No. 6, 02.02.2014, p. 521-8.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  10. Published

    The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis. / Sandahl, T D; McGrail, R; Møller, Holger Jon et al.

    In: Alimentary Pharmacology and Therapeutics, Vol. 43, No. 11, 06.2016, p. 1222-31.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  11. Published

    The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's disease. / Glavind, Emilie; Gotthardt, Daniel N.; Pfeiffenberger, Jan et al.

    In: Orphanet Journal of Rare Diseases, Vol. 15, 173, 07.2020.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review